PATENT CLAIM ANALYSIS

Application Number: 15873762
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
Methods are provided for attenuating or preventing μ-opioid receptor mediated tolerance and opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain or in need of opioid anesthesia.

Claim (Index 1):
A method of attenuating or preventing \u03bc-opioid receptor mediated tolerance or opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain or in need of opioid anesthesia, comprising\n ab initio administering to the subject a therapeutically effective amount of a composition including at least one peripherally acting \u03bc-opioid antagonist and at least one \u03bc-opioid agonist given concurrently or in essentially simultaneous sequence, wherein the administering of the composition is effective to attenuate or prevent \u03bc-opioid receptor mediated tolerance or opioid-induced hyperalgesia in said subject as evidenced by a decreased occurrence of symptoms generally associated with \u03bc-opioid receptor mediated tolerance or hyperalgesia.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10319789', '13560620', '13189954', '14246847', '13076386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7847079521795991
- 35 USC 102 Novelty (BERT): 0.5452395657597335
- Combined Prediction Score: 0.7607611135376126
- Mean Citation Score: 344.695056
- Max Citation Score: 414.39047
- Similarity Product: 293.75502125392563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test